This setup, when also applied in a syngeneic in vivo model, demonstrated enhanced tumor control and the proliferation of tumor-specific CD8+ T cells, illustrating a process known as cross-dressing in antigen presentation [272]. The gene discussed is CD8A; the disease is neoplasm.